NCT00005000View on ClinicalTrials.gov

Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

PHASE4UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 1999

Conditions
HIV Infections
Interventions
DRUG

Nelfinavir mesylate

DRUG

Efavirenz

DRUG

Lamivudine

DRUG

Keyhole-Limpet Hemocyanin

DRUG

Stavudine

DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (1)

92121

Agouron Pharmaceuticals Inc, San Diego

Sponsors
All Listed Sponsors
lead

Agouron Pharmaceuticals

INDUSTRY

NCT00005000 - Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs | Biotech Hunter | Biotech Hunter